BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nickel JC, Shoskes DA, Wagenlehner FM. Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact. World J Urol. 2013;31:747-753. [PMID: 23568442 DOI: 10.1007/s00345-013-1062-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Wagenlehner FM, Ballarini S, Naber KG. Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study. World J Urol. 2014;32:1595-1603. [PMID: 24482313 DOI: 10.1007/s00345-014-1247-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
2 Wang J, Yan D, Liang K, Xu Z. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol 2016;48:13-8. [PMID: 26577998 DOI: 10.1007/s11255-015-1147-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chiu B, Chung SD. Re: Kim et al.: The efficacy of extracorporeal magnetic stimulation for treatment of chronic prostatitis/chronic pelvic pain syndrome patients who do not respond to pharmacotherapy (Urology 2013;82:894-898). Urology 2014;83:959-60. [PMID: 24680462 DOI: 10.1016/j.urology.2013.12.049] [Reference Citation Analysis]
4 Magri V, Marras E, Restelli A, Wagenlehner FM, Perletti G. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med 2015;9:658-66. [PMID: 25667610 DOI: 10.3892/etm.2014.2152] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
5 Wu WL, Bamodu OA, Wang YH, Hu SW, Tzou KY, Yeh CT, Wu CC. Extracorporeal Shockwave Therapy (ESWT) Alleviates Pain, Enhances Erectile Function and Improves Quality of Life in Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome. J Clin Med 2021;10:3602. [PMID: 34441902 DOI: 10.3390/jcm10163602] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Salehi B, Butnariu M, Corneanu M, Sarac I, Vlaisavljevic S, Kitic D, Rahavian A, Abedi A, Karkan MF, Bhatt ID, Jantwal A, Sharifi-Rad J, Rodrigues CF, Martorell M, Martins N. Chronic pelvic pain syndrome: Highlighting medicinal plants toward biomolecules discovery for upcoming drugs formulation. Phytother Res 2020;34:769-87. [PMID: 31799719 DOI: 10.1002/ptr.6576] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Wang J, Zhang B, Jiao Y, Xu Z, Qian B, Wang Q. Involvement of prostatic interstitial cells of Cajal in inflammatory cytokines-elicited catecholamines production: Implications for the pathophysiology of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Biochemical and Biophysical Research Communications 2018;503:420-7. [DOI: 10.1016/j.bbrc.2018.04.050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
8 Zhao Q, Yang F, Meng L, Chen D, Wang M, Lu X, Chen D, Jiang Y, Xing N. Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-κB, MAPKs, and Nrf2 signaling pathways in rats. Andrology 2020;8:747-55. [PMID: 31880092 DOI: 10.1111/andr.12747] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
9 Zapico Goñi A, González Gea L, Ercilla Orbañanos J, Delgado Esparrago L, Pérez Balseiro V, Udina Cortés C. Tratamiento del dolor pélvico crónico mediante terapia neuroadaptativa. Clínica e Investigación en Ginecología y Obstetricia 2021;48:81-6. [DOI: 10.1016/j.gine.2020.04.008] [Reference Citation Analysis]
10 Naveed M, Changxing L, Ihsan AU, Shumzaid M, Kamboh AA, Mirjat AA, Saeed M, Baig MMFA, Zubair HM, Noreen S, Madni A, Xiaohui Z. Therapeutic interventions to urologic chronic pelvic pain syndrome and UPOINT system for clinical phenotyping: How far are we? Urologia 2022;:3915603211065301. [PMID: 34978224 DOI: 10.1177/03915603211065301] [Reference Citation Analysis]
11 DeWitt-Foy ME, Nickel JC, Shoskes DA. Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Eur Urol Focus 2019;5:2-4. [PMID: 30206001 DOI: 10.1016/j.euf.2018.08.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
12 Nickel JC. Understanding chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). World J Urol 2013;31:709-10. [PMID: 23812415 DOI: 10.1007/s00345-013-1121-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
13 Koh JS, Ko HJ, Wang SM, Cho KJ, Kim JC, Lee SJ, Pae CU. The impact of depression and somatic symptoms on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: a preliminary study in a naturalistic treatment setting. Int J Clin Pract 2014;68:478-85. [PMID: 24471930 DOI: 10.1111/ijcp.12340] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mohiuddin M, Park R, Wesselmann U, Pukall C, Jarvi K, Nickel C, Doiron C, Gilron I. Efficacy and Safety of Drug Combinations for Chronic Pelvic Pain: Protocol for a Systematic Review. JMIR Res Protoc 2021;10:e21909. [PMID: 33999006 DOI: 10.2196/21909] [Reference Citation Analysis]
15 Urits I, Schwartz R, Bangalore Siddaiah H, Kikkeri S, Chernobylsky D, Charipova K, Jung JW, Imani F, Khorramian M, Varrassi G, Cornett EM, Kaye AD, Viswanath O. Inferior Hypogastric Block for the Treatment of Chronic Pelvic Pain. Anesth Pain Med 2021;11:e112225. [PMID: 34221944 DOI: 10.5812/aapm.112225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Huang X, Chen J, Liu S, Gong Q, Liu T, Lu C, Qin Z, Cui H, Chen Y, Zhu Y. Impaired frontal‐parietal control network in chronic prostatitis/chronic pelvic pain syndrome revealed by graph theoretical analysis: A DTI study. Eur J Neurosci 2021;53:1060-71. [DOI: 10.1111/ejn.14962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cao Y, Cheng Y, Ihsan AU, Khan FU, Xie D, Cui X, Wang W, Zhou X. A nanoparticle‐coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model. Fundam Clin Pharmacol 2019;33:267-76. [DOI: 10.1111/fcp.12438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
18 Koh JS, Ko HJ, Wang SM, Cho KJ, Kim JC, Lee SJ, Pae CU, Serretti A. The association of personality trait on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: an exploratory study. J Psychosom Res 2014;76:127-33. [PMID: 24439688 DOI: 10.1016/j.jpsychores.2013.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
19 Appiya Santharam M, Khan FU, Naveed M, Ali U, Ahsan MZ, Khongorzul P, Shoaib RM, Ihsan AU. Interventions to chronic prostatitis/Chronic pelvic pain syndrome treatment. Where are we standing and what's next? Eur J Pharmacol 2019;857:172429. [PMID: 31170381 DOI: 10.1016/j.ejphar.2019.172429] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Doiron RC, Shoskes DA, Nickel JC. Male CP/CPPS: where do we stand? World J Urol 2019;37:1015-22. [PMID: 30864007 DOI: 10.1007/s00345-019-02718-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
21 Tripp DA, Nickel JC, Katz L, Krsmanovic A, Ware MA, Santor D. A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome. Can Urol Assoc J 2014;8:E901-5. [PMID: 25553163 DOI: 10.5489/cuaj.2268] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
22 Chen Y, Chen S, Zhang J, Wang Y, Jia Z, Zhang X, Han X, Guo X, Sun X, Shao C, Wang J, Lan T. Expression profile of microRNAs in expressed prostatic secretion of healthy men and patients with IIIA chronic prostatitis/chronic pelvic pain syndrome. Oncotarget 2018;9:12186-200. [PMID: 29552302 DOI: 10.18632/oncotarget.24069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
23 Doggweiler R, Whitmore KE, Meijlink JM, Drake MJ, Frawley H, Nordling J, Hanno P, Fraser MO, Homma Y, Garrido G, Gomes MJ, Elneil S, van de Merwe JP, Lin ATL, Tomoe H. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society. Neurourol Urodyn 2017;36:984-1008. [PMID: 27564065 DOI: 10.1002/nau.23072] [Cited by in Crossref: 73] [Cited by in F6Publishing: 49] [Article Influence: 12.2] [Reference Citation Analysis]
24 Gao J, Xu C, Liang C, Su P, Peng Z, Shi K, Tang D, Gao P, Lu Z, Liu J, Xia L, Yang J, Hao Z, Zhou J, Zhang X. Relationships between intravaginal ejaculatory latency time and national institutes of health-chronic prostatitis symptom index in the four types of premature ejaculation syndromes: a large observational study in China. J Sex Med 2014;11:3093-101. [PMID: 25307084 DOI: 10.1111/jsm.12696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
25 Khan A, Murphy AB. Updates on therapies for chronic prostatitis/chronic pelvic pain syndrome. World J Pharmacol 2015; 4(1): 1-16 [DOI: 10.5497/wjp.v4.i1.1] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
26 Piontek K, Ketels G, Klotz SGR, Dybowski C, Brünahl C, Löwe B. The longitudinal association of symptom-related and psychological factors with health-related quality of life in patients with chronic pelvic pain syndrome. J Psychosom Res 2021;153:110707. [PMID: 34954604 DOI: 10.1016/j.jpsychores.2021.110707] [Reference Citation Analysis]
27 Kim KS, Moon HS. The Effect of α-Blockers Monotherapy vs. Combination Antibiotic Therapy on Symptom Alleviation in Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Urogenit Tract Infect 2018;13:1. [DOI: 10.14777/uti.2018.13.1.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Kocjancic E, Chung E, Garzon JA, Haylen B, Iacovelli V, Jaunarena J, Locke J, Millman A, Nahon I, Ohlander S, Pang R, Plata M, Acar O. International Continence Society (ICS) report on the terminology for sexual health in men with lower urinary tract (LUT) and pelvic floor (PF) dysfunction. Neurourol Urodyn 2022;41:140-65. [PMID: 34989425 DOI: 10.1002/nau.24846] [Reference Citation Analysis]
29 Wagenlehner FM, van Till JO, Houbiers JG, Martina RV, Cerneus DP, Melis JH, Majek A, Vjaters E, Urban M, Ramonas H, Shoskes DA, Nickel JC. Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled Trial. Urology 2017;103:191-7. [DOI: 10.1016/j.urology.2017.02.029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
30 Anderson RU, Wise D, Nathanson BH. Chronic Prostatitis and/or Chronic Pelvic Pain as a Psychoneuromuscular Disorder-A Meta-analysis. Urology 2018;120:23-9. [PMID: 30056195 DOI: 10.1016/j.urology.2018.07.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
31 Wang Y, Chen C, Zhu C, Chen L, Han Q, Ye H. Social Determinants of Chronic Prostatitis/Chronic Pelvic Pain Syndrome Related Lifestyle and Behaviors among Urban Men in China: A Case-Control Study. Biomed Res Int 2016;2016:1687623. [PMID: 27579305 DOI: 10.1155/2016/1687623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Koh JS, Ko HJ, Wang SM, Cho KJ, Kim JC, Lee SJ, Pae CU. Depression and somatic symptoms may influence on chronic prostatitis/chronic pelvic pain syndrome: a preliminary study. Psychiatry Investig. 2014;11:495-498. [PMID: 25395984 DOI: 10.4306/pi.2014.11.4.495] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
33 Doiron RC, Nickel JC. Management of chronic prostatitis/chronic pelvic pain syndrome. Can Urol Assoc J 2018;12:S161-3. [PMID: 29875042 DOI: 10.5489/cuaj.5325] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
34 Kang SW, Park JH, Seok H, Park HJ, Chung JH, Kim CJ, Kim YO, Han YR, Hong D, Kim YS, Kim SK. The Effects of Korea Red Ginseng on Inflammatory Cytokines and Apoptosis in Rat Model with Chronic Nonbacterial Prostatitis. Biomed Res Int 2019;2019:2462561. [PMID: 30756082 DOI: 10.1155/2019/2462561] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
35 Ihsan AU, Khan FU, Khongorzul P, Ahmad KA, Naveed M, Yasmeen S, Cao Y, Taleb A, Maiti R, Akhter F, Liao X, Li X, Cheng Y, Khan HU, Alam K, Zhou X. Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress. Biomedicine & Pharmacotherapy 2018;106:714-23. [DOI: 10.1016/j.biopha.2018.06.139] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]